Clinical Trial: SWOG S2013

SWOG S2013

Status: Open

NCT#04871542

Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

Eligible for screening study DCP 001

Completion of Pre-Registration QOLs is required after consent, prior to registration. Please see study documents.

S2013, Cohort 2 is open to accrual & Cohort 1 is closed to accrual effective November 19, 2024 with the implementation of Revision 6

The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Available Clinical Trials

Clinical Trial: SWOG S2013

SWOG S2013

NCT#04871542

Navigation

About Us

Contact Us